Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2a First-in-human Trial Evaluating Autologous Gene-edited Muscle Stem Cells in Limb Girdle Muscular Dystrophies (GenPHSats-bASKet)

NCT05588401 is registered in ClinicalTrials.gov with Simone Spuler, MD as lead sponsor.

NCT NCT05588401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05588401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2a First-in-human Trial Evaluating Autologous Gene-edited Muscle Stem Cells in Limb Girdle Muscular Dystrophies (GenPHSats-bASKet)
Lead sponsor
Simone Spuler, MD
Phase
Phase 1/2
Overall status
Unknown status
Start date
July 1, 2024
Completion date
July 1, 2025
Enrollment
6 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lgmd